Related Experiment Video
Updated: Sep 30, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrioventricular nodal modification and atrioventricular junctional ablation for control of ventricular rate in
C Narasimhan1, Z Blanck, M Akhtar
1Sinai Samaritan Medical Center, Electrophysiology Laboratories, Milwaukee, Wisconsin, USA.
Insights
Nonpharmacologic therapies, like AV nodal ablation, effectively manage rapid heart rates in atrial fibrillation when drugs fail. These procedures improve symptoms and heart function, offering a viable alternative for rate control.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Ablation
Background:
- Atrial fibrillation causes heart changes, worsening ventricular function.
- Restoring sinus rhythm isn't always possible or effective.
- Pharmacologic therapy for rapid ventricular response (RVR) has limitations.
Purpose of the Study:
- To review nonpharmacologic therapy for managing RVR in atrial fibrillation.
- To discuss AV nodal modification and ablation strategies.
- To evaluate the efficacy of these procedures for long-term rate control.
Main Methods:
- Review of electrophysiologic studies identifying posterior AV nodal inputs.
- Description of AV nodal modification via sequential ablation.
- Comparison with AV nodal ablation and permanent pacemaker implantation.
Main Results:
- AV nodal modification successfully controlled ventricular response in ~70% of patients long-term.
- AV nodal ablation with pacemaker implantation is definitive and simpler.
- Both nonpharmacologic approaches improved clinical symptoms and left ventricular function.
Conclusions:
- Nonpharmacologic therapy is a crucial option for atrial fibrillation rate control.
- Consider these interventions when pharmacologic therapy is ineffective or poorly tolerated.
- These methods offer significant benefits for patients with difficult-to-manage RVR.
Abstract:
Atrial fibrillation results in several structural and functional changes in the heart that lead to worsening ventricular function. Although restoration of sinus rhythm is the ideal goal, it is not always feasible. Pharmacologic therapy is associated with adverse effects and is not always effective. We have reviewed the current status of nonpharmacologic therapy in the management of rapid ventricular response due to atrial fibrillation. Electrophysiologic studies have confirmed that the posterior inputs to the AV node have a shorter refractory period and are mainly responsible for maintaining rapid ventricular response in atrial fibrillation. AV nodal modification involves ablation of these posterior inputs in a sequential fashion until a significant reduction of ventricular response is achieved. This procedure has been reported to be successful in maintaining the controlled ventricular response in about 70% of the patients over long-term follow-up. Ablation of the AV node with implantation of a permanent pacemaker is a more definitive procedure and simpler to perform. Reduction in ventricular response achieved with this procedure results in improvement of the patient's clinical symptoms as well as the underlying left ventricular function. Nonpharmacologic therapy for control of ventricular rate should be considered for patients with atrial fibrillation, in whom pharmacologic therapy for rate control is ineffective or poorly tolerated.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

